Dr. Rana Herro, Ph.D

Rana Herro, Ph.D. Scientific Advisory Board Member, Praespero Associate Professor, Department of Pediatrics, University of Cincinnati College of Medicine; Cincinnati Children's Hospital Medical Center
Key Achievements
Praespero Innovation Award winner for research on the "atopic march" toward autoimmunity
Investigating whether TNF superfamily molecules can be targeted to treat fibrotic and inflammatory diseases
Leveraged Praespero-supported foundational work into major federal grant funding
Expanded her research from fibrosis and allergy into lung cancer, showing how closely immunology, fibrosis, and cancer are connected
Recognized within Praespero's network as a collaborator and connector who builds bridges across disciplines
ABOUT
Rana Herro is an immunologist at Cincinnati Children's whose work focuses on fibrosis, a process of tissue scarring that contributes to more than 45% of deaths in the United States. Her goal is to develop effective therapies and new prognostic biomarkers for fibrotic disease. She is particularly interested in members of the tumor necrosis factor (TNF) superfamily and their roles in inflammation and fibrosis. Her lab investigates whether these molecules can be targeted to ease symptoms and potentially cure fibrosis-related conditions, including idiopathic pulmonary fibrosis, systemic sclerosis, non-alcoholic steatohepatitis, neutrophilic asthma, and atopic dermatitis.
Beyond the lab, Dr. Herro is a connector and communicator who shares her research at conferences and builds new relationships across fields. On Praespero's Scientific Advisory Board, she brings the pioneering, boundary-pushing thinking that Praespero exists to support, helping advance its mission to foster innovation, collaboration, and cross-disciplinary research into the root causes of autoimmune disease.
With Praespero's funding, Dr. Herro investigated the "atopic march," a dangerous progression some patients experience that begins with eczema, develops into severe, treatment-resistant asthma, and can end in life-threatening food allergies. Her insight was to search for a hidden autoimmune component that might be driving this allergic response, with the aim of stopping the progression early. This foundational work in fibrosis and immune responses helped her secure major federal grant funding. Her research has since expanded to lung cancer, building on her expertise in fibrotic disease and showing how the mechanisms of immunology, fibrosis, and cancer are deeply interconnected.
